A D S Diagnostic Ltd
ADS Diagnostic supplies and trades medical equipment. The Company offers patient monitoring systems and ultrasound machines.
- Market Cap ₹ Cr.
- Current Price ₹ 11.3
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 32.5
- Dividend Yield 8.82 %
- ROCE 16.2 %
- ROE 12.8 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.35 times its book value
- Stock is providing a good dividend yield of 8.82%.
- Company is expected to give good quarter
Cons
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.33 | 7.44 | 11.67 | 5.26 | 6.38 | 8.95 | 13.52 | 9.43 | 10.10 | 13.29 | 23.96 | 16.00 | 27.82 | |
| 6.93 | 6.75 | 10.38 | 6.01 | 5.65 | 7.41 | 12.96 | 9.33 | 9.11 | 11.79 | 20.83 | 14.60 | 25.78 | |
| Operating Profit | 0.40 | 0.69 | 1.29 | -0.75 | 0.73 | 1.54 | 0.56 | 0.10 | 0.99 | 1.50 | 3.13 | 1.40 | 2.04 |
| OPM % | 5.46% | 9.27% | 11.05% | -14.26% | 11.44% | 17.21% | 4.14% | 1.06% | 9.80% | 11.29% | 13.06% | 8.75% | 7.33% |
| 0.10 | 0.11 | -0.14 | 0.82 | 0.29 | 0.18 | 0.81 | 1.19 | 0.36 | -0.38 | 0.10 | 0.13 | 0.00 | |
| Interest | 0.20 | 0.31 | 0.42 | 0.55 | 0.51 | 0.45 | 0.48 | 0.56 | 0.51 | 0.44 | 0.57 | 0.30 | 0.54 |
| Depreciation | 0.20 | 0.30 | 0.21 | 0.16 | 0.15 | 0.16 | 0.27 | 0.29 | 0.28 | 0.19 | 0.16 | 0.15 | 0.11 |
| Profit before tax | 0.10 | 0.19 | 0.52 | -0.64 | 0.36 | 1.11 | 0.62 | 0.44 | 0.56 | 0.49 | 2.50 | 1.08 | 1.39 |
| Tax % | 70.00% | 57.89% | 42.31% | -18.75% | 41.67% | 22.52% | 24.19% | 25.00% | 23.21% | 16.33% | 26.00% | 25.93% | |
| 0.04 | 0.08 | 0.31 | -0.52 | 0.21 | 0.85 | 0.47 | 0.34 | 0.44 | 0.41 | 1.85 | 0.81 | 1.03 | |
| EPS in Rs | 0.18 | 0.36 | 1.41 | -2.37 | 0.96 | 3.88 | 2.14 | 1.55 | 2.01 | 1.87 | 8.44 | 3.69 | 4.69 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 23.82% | 0.00% | 0.00% | 40.91% | 0.00% | 0.00% | 27.78% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 3% |
| 3 Years: | 17% |
| TTM: | 49% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 12% |
| 3 Years: | 25% |
| TTM: | -3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 19% |
| 3 Years: | 23% |
| Last Year: | 13% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 |
| Reserves | -0.09 | -0.10 | 0.21 | -0.31 | -0.10 | 0.77 | 1.07 | 1.41 | 1.85 | 2.13 | 3.77 | 4.34 | 4.88 |
| 2.00 | 2.19 | 4.45 | 4.19 | 3.79 | 1.81 | 5.51 | 5.29 | 3.99 | 2.54 | 2.08 | 2.31 | 6.26 | |
| 2.32 | 2.67 | 7.17 | 2.35 | 4.18 | 11.93 | 8.54 | 5.63 | 3.92 | 5.05 | 7.83 | 10.25 | 16.55 | |
| Total Liabilities | 6.48 | 7.01 | 14.08 | 8.48 | 10.12 | 16.76 | 17.37 | 14.58 | 12.01 | 11.97 | 15.93 | 19.15 | 29.94 |
| 0.73 | 1.06 | 1.58 | 1.38 | 1.11 | 2.10 | 1.84 | 1.55 | 1.15 | 0.37 | 0.22 | 0.26 | 0.21 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| 5.75 | 5.95 | 12.50 | 7.06 | 8.97 | 14.62 | 15.49 | 12.99 | 10.82 | 11.56 | 15.67 | 18.85 | 29.69 | |
| Total Assets | 6.48 | 7.01 | 14.08 | 8.48 | 10.12 | 16.76 | 17.37 | 14.58 | 12.01 | 11.97 | 15.93 | 19.15 | 29.94 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.80 | 1.16 | 1.14 | -1.60 | 0.89 | 3.82 | -3.98 | 0.53 | 1.74 | 1.44 | 1.99 | 0.78 | |
| -0.46 | -1.15 | -0.88 | 0.62 | 0.15 | -1.07 | 0.08 | 0.09 | 0.24 | 0.68 | 0.06 | -0.12 | |
| -0.20 | -0.22 | -0.50 | 1.13 | 0.09 | -2.35 | 2.83 | -0.09 | -2.00 | -3.18 | -1.22 | -0.34 | |
| Net Cash Flow | 0.14 | -0.21 | -0.23 | 0.15 | 1.13 | 0.41 | -1.07 | 0.53 | -0.03 | -1.06 | 0.83 | 0.31 |
| Free Cash Flow | 0.79 | 0.44 | 0.06 | -1.46 | 0.93 | 2.67 | -3.99 | 0.52 | 1.91 | 2.06 | 1.98 | 0.57 |
| CFO/OP | 210% | 186% | 105% | 191% | 127% | 260% | -684% | 530% | 187% | 113% | 79% | 97% |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 56.77 | 60.34 | 182.97 | 136.01 | 127.01 | 106.44 | 137.68 | 174.57 | 123.59 | 75.53 | 78.76 | 98.09 |
| Inventory Days | 199.41 | 237.59 | 196.37 | 283.74 | 280.52 | 186.28 | 468.76 | |||||
| Days Payable | 175.38 | 200.86 | 203.85 | 161.19 | 171.67 | 79.83 | 382.21 | |||||
| Cash Conversion Cycle | 80.80 | 97.07 | 175.50 | 258.56 | 127.01 | 106.44 | 137.68 | 174.57 | 123.59 | 184.38 | 185.20 | 184.65 |
| Working Capital Days | -21.41 | -50.53 | -34.40 | -4.86 | 0.57 | -30.99 | 25.38 | 58.83 | 57.10 | 74.70 | 67.33 | 102.20 |
| ROCE % | 6.88% | 12.24% | 22.93% | -0.77% | 15.74% | 28.97% | 16.11% | 11.25% | 12.09% | 23.85% | 40.88% | 16.24% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees count |
|
||||||||
| Revenue Mix - Distribution Commission Income INR in '000s |
|||||||||
| Revenue Mix - Income from Servicing and Installation INR in '000s |
|||||||||
| Revenue Mix - Sale of Trading Goods INR in '000s |
|||||||||
| Gross Block of Assets Given on Operating Lease INR in million |
|||||||||
| Warranty and Maintenance Expenses INR in million |
|||||||||
Extracted by Screener AI
Documents
Announcements
-
Compliance Under Regulation 6(1) And 7(1) Of SEBI (Listing Obligation And Disclosure Requirement) Regulation -2015 For The Quarter Ended 31.03.2026
5h - Quarterly compliance filed; no change in CS since 1996, and no external RTA appointed.
-
With Reference To The Above-Mentioned Subject, The Compliance Certificate Pursuant To Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Year Ended 31St March, 2026 Given By Mr. Nitesh Kumar Singh, Practicing Company Secretary (M. No.54016 & COP No.20066) Is Enclosed With This Letter.
6h - Submitted Regulation 40(9) compliance certificate for year ended 31 March 2026.
-
Board Meeting Outcome for Outcome Of The Board Meeting For The Quarter Ended June 30, 2023 - SEBI Regulations, 2015- Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015Company Code - 523031
13 Feb - ADS Diagnostic approved unaudited standalone results for quarter ended Dec 31, 2025; board met Feb 13, 2026.
-
Board Meeting Intimation for Notice Of Board Meeting
3 Feb - Board meeting on 13 February 2026 to approve unaudited results for quarter ended 31 Dec 2025.
-
Board Meeting Outcome for Outcome Of Board Meeting
12 Nov 2025 - Unaudited financial results for quarter/half-year ended 30 Sep 2025; auditor review report dated 12 Nov 2025.